China National Pharmaceutical Group
sinopharm.com Direct investor
国药集团是由国务院国资委直接管理的以生命健康为主业的中央企业，拥有科技研发、工业制造、物流分销、零售连锁、医疗健康、工程技术、专业会展、国际经营、金融投资等大健康全产业链。其子公司中国医药投资有限公司等企业聚焦医药健康高端制造和新兴服务领域进行投资。
China National Pharmaceutical Group is an investor headquartered in Beijing, China. It invests directly in companies, in 医药健康, 高端制造 and 新兴服务. 20 portfolio companies, as it reports.
“中国医药投资有限公司等企业，聚焦医药健康高端制造和新兴服务领域，先后投资了20余家细分行业龙头企业，涵盖了抗肿瘤、生化诊断、病理诊断、医药研发、医药包装等17个细分领域，拥有多家国家专精特新“小巨人”企业及高新技术企业，实现产业投资与实业板块间的协同共享。”
— China National Pharmaceutical Group, own website
- Layer
- Direct investor
- Type
- Other
- Stage
- Unknown
- Invests in
- China
- Sectors
- 医药健康, 高端制造, 新兴服务
- Portfolio
- 20 companies
Where this comes from
Every fact above was read from a page China National Pharmaceutical Group publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.sinopharm.com/aboutus.htmlname, description
- https://www.sinopharm.com/is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, thesis_quote, thesis_quote_page, portfolio_count, status
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 6201 · added 2026-09-03 · link last verified 2026-09-06 · confidence medium
Similar investors
- China Internet Investment FundOther · Seed – Growth · Beijing, China
- 北京中关村科学城建设股份有限公司Other · Beijing, China
- 北京金融街资本运营集团有限公司Other · Beijing, China
- China Great Wall Asset Management Co., Ltd.Other · Beijing, China
- Fosun CapitalOther · Shanghai, China
- Hina GroupOther · Seed – Growth · Beijing, China